Breaking News

CordenPharma Establishes Technology & Science Advisory Board of Experts

Aims to provide valuable insights into emerging trends, cutting-edge technologies, and regulatory advancements.

CordenPharma, a CDMO, created a new Technology & Science Advisory Board (TSAB) with eight experts from academia and industry to provide strategic guidance and scientific expertise to drive the company’s continued growth and innovation. By harnessing the knowledge and insights of renowned scientists and industry leaders, the company aims to enhance its capabilities in the efficient development and manufacturing of APIs, lipid excipients, drug products, and integrated supply to suppor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters